Discover more insights into Blocks Programmed 程序块

Keywords frequently search together with Blocks Programmed 程序块

Narrow sentence examples with built-in keyword filters

Blocks Programmed sentence examples within cell death ligand



Abstract A006: Phase 1 study to evaluate the safety and tolerability of MEDI4736 (durvalumab, durva) + tremelimumab (treme) in patients with advanced solid tumors


Abstract B209: Phase 1/2 study of mRNA vaccine therapy + durvalumab (durva) ± tremelimumab (treme) in patients with metastatic non-small cell lung cancer (NSCLC)

Blocks Programmed sentence examples within blocks programmed cell



Stuck at the Checkpoint: Pembrolizumab Induced Hypophysitis With ‘Normal’ Cosyntropin Response


Single-Dose Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy


Immune checkpoint inhibitor toxicity: A new indication for therapeutic plasma exchange?



Stuck at the Checkpoint: Pembrolizumab Induced Hypophysitis With ‘Normal’ Cosyntropin Response



Single-Dose Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy



Towards Polymeric Nanoparticles with Multiple Magnetic Patches



Tuberculous Lymphadenitis in a Patient Receiving PD-1 Inhibitor for Melanoma: A Case Report and Brief Literature Review



Tissue-autonomous immune response regulates stress signalling during hypertrophy


More Blocks Programmed 程序块 sentence examples
10.1158/2326-6074.CRICIMTEATIAACR18-A006

Abstract A006: Phase 1 study to evaluate the safety and tolerability of MEDI4736 (durvalumab, durva) + tremelimumab (treme) in patients with advanced solid tumors


More Blocks Programmed 程序块 sentence examples
10.1158/2326-6074.CRICIMTEATIAACR18-B209

Abstract B209: Phase 1/2 study of mRNA vaccine therapy + durvalumab (durva) ± tremelimumab (treme) in patients with metastatic non-small cell lung cancer (NSCLC)



Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort.



Clinical Activity, Tolerability, and Long-term Follow-up of Durvalumab in Patients With Advanced NSCLC.


More Blocks Programmed 程序块 sentence examples
10.1158/1538-7445.SABCS18-OT3-01-01

Abstract OT3-01-01: BEGONIA: Phase Ib/II open-label, platform study of safety and efficacy of durvalumab, paclitaxel and other novel oncology therapy agents as first-line (1L) therapy in patients with metastatic triple negative breast cancer (mTNBC)



A Case of Acute Exacerbation of Chronic Adrenal Insufficiency Due to Ipilimumab Treatment for Advanced Melanoma


Learn more from Blocks Programmed 程序块

Blocks Programmed 程序块


Blocks Programmed 程序块
Encyclopedia 百科全书